The European metered dose inhaler market was valued at around $2.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.8% during the forecast period. Major countries that will contribute to the metered dose inhaler market within the region includes UK, Germany, France, Italy, and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the metered dose inhaler market.

The European metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting broncho dilators inhaler are analyzed. The preventive metered dose inhaler segment led the global Metered Dose Inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, home care and hospitals and clinics have been analyzed.


(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/european-metered-dose-inhaler-market

The market study of the European Metered Dose Inhaler Market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
Financial reports of companies involved in the market
White papers, research-papers, and news blogs
Company websites and their product catalog

The report is intended for dry powdered inhaler manufacturers, contract research organizations (CROs), healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.


A Full Report of Global North American Metered Dose Inhaler Marketis Available at: https://www.omrglobal.com/industry-reports/european-metered-dose-inhaler-market


Company Profiles
3M Co.
Adherium Ltd.
Aradigm Corp.
 AstraZeneca PLC
Boehringer Ingelheim International GmbH
 Cipla Ltd.
Gerresheimer AG
GlaxoSmithKline PLC
 Koninklijke Philips N.V.
Novartis AG
 ResMed Corp.
Sunovion Pharmaceuticals
Teva Pharmaceuticals Industries Ltd.

Global European Metered Dose Inhaler Market- Segmentation

European Metered Dose Inhaler Market by Type
Preventive Inhaler
Reliever Inhaler
Long Acting Bronchodilators Dry Powdered Inhaler 
European Metered Dose Inhaler Market by Application
 Asthma 
 Chronic Obstructive Pulmonary Disease (COPD)
European Metered Dose Inhaler Market by End-User
 Homecare
 Hospitals and Clinics


Global European Metered Dose Inhaler Market- Segmentation
By Region 

North America 

United States
Canada


Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe


Asia-Pacific 

China
Japan
India
Rest of Asia-Pacific


Rest of the World

Middle East & Africa 
Latin America



For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-metered-dose-inhaler-market

Reasons to Buying From us –
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.


About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404